发明名称 |
Sustained release suppositories and a process for preparation |
摘要 |
A sustained release suppository comprising in a usual suppository base a) a water-soluble therapeutically active substance, the average particle size of which is smaller than 20 mu m, b) a physiologically acceptable organic substance which is swellable in contact with water, and c) hydrophobic silicium dioxide. The suppository base is usually a fat having a melting range of from 29 DEG to 38 DEG C. As ingredient b) cellulose derivatives such as hydroxypropylmethylcellulose may be used, in a quantity of from 5 to 40% by weight, preferably 9 to 15% by weight. Ingredient c) is preferably used in a quantity of from 3 to 6% by weight. Also a process for manufacturing the suppositories is described.
|
申请公布号 |
US5436009(A) |
申请公布日期 |
1995.07.25 |
申请号 |
US19920990888 |
申请日期 |
1992.12.15 |
申请人 |
DAGRA PHARMA B.V. |
发明人 |
JAUW, TJOE H.;FRIJLINK, HENDRIK W.;MOOLENAAR, FRITS;MEIJLINK, PETER |
分类号 |
A61J3/08;A61K9/02;A61K31/485;(IPC1-7):A61M31/00 |
主分类号 |
A61J3/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|